Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [BUSINESS]
2 clusters · 10 sources · 4 days · First seen · Last updated
Pfizer financial performance and market recovery
Overview
Pfizer has demonstrated signs of financial recovery, with its shares reaching a 52-week high. The company is implementing cost-reduction programs aimed at achieving up to $6.7 billion in savings through 2029.
Following third-quarter results that exceeded analyst expectations, Pfizer raised its full-year 2026 revenue forecast to a range between US$62 billion and US$64 billion, up from a previous forecast of US$60.5 billion to US$62.5 billion. This upward revision is attributed to 32 percent operational growth in newly launched and acquired products, such as Eliquis and Padcev, which helped offset declining sales of COVID-19 related products like Comirnaty and Paxlovid. Specifically, Eliquis saw a 25 percent increase in sales to $2.52 billion, while the cancer therapy Padcev grew 55 percent operationally.
Consequently, the company also increased its adjusted diluted earnings guidance to a range of US$2.95 to US$3.05 per share. Additionally, Pfizer confirmed that Cecile Guegan has officially assumed the role of Chief Financial Officer, succeeding her interim status.
Entities
Cecile Guegan · Eliquis · Pfizer · Albert Bourla · Pfizer Inc.
Timeline
-
[BUSINESS] 9 sourcesPfizer raises 2026 revenue guidance following third-quarter earnings beat
Pfizer raised its 2026 revenue guidance to $62–$64 billion after third-quarter results beat estimates, driven by strong sales of Eliquis and new cancer treatments despite declining COVID-19 product revenue.
-
[BUSINESS] 2 sourcesPfizer shares reach 52-week high amid recovery efforts
Pfizer shares have hit a 52-week high as the company implements cost-cutting measures and sees growth in cancer and blood thinner treatments to offset declining COVID-19 product sales.
Sources
akcie.cz · businessnews.com.my · careeraheadonline.com · it-boltwise.de · mugglehead.com · rande-academy.cz · rocketnews.com · teleborsa.it · theascent.com · tradingview.com
This summary has been updated 1 time: see revision history